Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Molecular 'brake' found for neurofibromatosis 1

26.06.2006
A team led by Duke University Medical Center researchers has identified in yeast a molecular "brake" that could inhibit the proliferation of cells that characterizes neurofibromatosis 1, a common hereditary disorder that causes potentially troublesome tumors along nerve fibers.

This brake is a protein that appears to stop the cascade of molecular events that leads to the activation of a cancer-producing gene, or oncogene, that causes the tumors. The oncogene, called Ras, was one of the first oncogenes ever discovered and has been implicated in more than half of all human cancers.

The new finding could have important medical implications, the researchers said, since the gene involved and the processes that regulate its activation are the same in humans as in yeasts. Similar genes in different species are known as homologs.

The researchers reported their findings in the June 23, 2006, issue of the journal Molecular Cell. The study was supported by the National Institutes of Health, the Children's Tumor Foundation, and the Department of Defense's Neurofibromatosis Foundation.

Neurofibromatosis 1 occurs in about one in 3,500 newborn children and is characterized by multiple growths, or neurofibromas, on or under the skin, usually along nerve fibers. Occasionally, the neurofibromas become large and disfiguring, or develop on the brain or spinal cord. About half of patients with neurofibromatosis 1 have learning disabilities.

The Duke researchers focused their attention on the neurofibromatosis 1 gene, which contains the blueprint for the production of neurofibromin, a protein found primarily in nerve cells. A tumor-suppressor protein, neurofibromin keeps the Ras gene in check and prevents abnormal cell growth.

"We know that patients with neurofibromatosis 1 have defects, or mutations, in the neurofibromin gene," said lead researcher Joseph Heitman, M.D., Ph.D. "As a consequence, the protein it produces becomes unstable and can no longer effectively suppress the Ras oncogene. As a result, Ras becomes over-stimulated, and this in turn leads to the formation of the tumors along the nerve fivers."

Scientists have not fully understood how and why the mutated neurofibromin gene leads to activation of the Ras oncogene. In the current study, the researchers discovered two novel proteins that appear to be necessary in neurofibromin's ability to regulate Ras. The team named these novel proteins Gpb1 and Gbp2.

"When the two proteins are present, they keep the yeast neurofibromin homologs stabilized, effectively blocking the molecular signaling pathway that activates Ras," said Toshiaki Harashima, Ph.D., first author of the study. Harashima, a cell biologist, worked as a senior postdoctoral fellow in Heitman's laboratory and now is at the National Institute for Basic Biology in Japan.

"Our findings add to basic understanding of how neurofibromin is stabilized," Harashima said. "By shedding light on these fundamental processes, we hope we can help in the development of new drugs or therapies to block the activation of Ras and prevent this disease."

According to Heitman, yeast, a member of the fungus family, can serve as an effective model for studying basic molecular processes in humans, beyond those involved in neurofibromatosis 1, because the signaling pathways of many genes are remarkably similar in both types of organisms.

"These processes have remained in the genomes of yeasts and humans over a billion years of evolution," Heitman said. "Now that scientists have mapped the entire genome of the baker's yeast we study, Saccharomyces cerevisiae, we are able to look for human gene equivalents using all the latest experimental methods that have been developed over the years using yeasts."

Richard Merritt | EurekAlert!
Further information:
http://www.mc.duke.edu

More articles from Life Sciences:

nachricht 'Y' a protein unicorn might matter in glaucoma
23.10.2017 | Georgia Institute of Technology

nachricht Microfluidics probe 'cholesterol' of the oil industry
23.10.2017 | Rice University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>